A consensus panel from the United States and Europe was convened recently to update and revise the 1997 consensus guidelines for the neuropathologic evaluation of Alzheimer’s disease (AD) and other diseases of brain that are common in the elderly. The new guidelines recognize the pre-clinical stage of AD, enhance the assessment of AD to include amyloid accumulation as well as neurofibrillary change and neuritic plaques, establish protocols for the neuropathologic assessment of Lewy body disease, vascular brain injury, hippocampal sclerosis, and TDP-43 inclusions, and recommend standard approaches for the workup of cases and their clinico-pathologic correlation.
Alzheimer’s Disease Definition and General. . . .
What Are the Causes of Alzheimer’s Disease? The exact. . . .
Alzheimer’s Disease (AD) is a progressive neurodegenerative. . . .
Alzheimer’s is a progressive neurodegenerative disease.. . . .
In addition to medications, other care and management strategies. . . .
Alzheimer's Disease Treatment Alzheimer’s is a. . . .